News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,357 Results
Type
Article (30417)
Company Profile (149)
Press Release (363791)
Section
Business (101274)
Career Advice (654)
Deals (16547)
Drug Delivery (51)
Drug Development (63976)
Employer Resources (48)
FDA (11269)
Job Trends (8642)
News (192089)
Policy (16643)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (5)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (4)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
Academia (1962)
Academic (1)
Accelerated approval (4)
Adcomms (19)
Allergies (62)
Alliances (30288)
ALS (81)
Alzheimer's disease (1041)
Antibody-drug conjugate (ADC) (120)
Approvals (11269)
Artificial intelligence (184)
Autoimmune disease (17)
Automation (10)
Bankruptcy (130)
Best Places to Work (7468)
BIOSECURE Act (8)
Biosimilars (72)
Biotechnology (116)
Bladder cancer (59)
Brain cancer (28)
Breast cancer (228)
Cancer (1920)
Cardiovascular disease (113)
Career advice (550)
Career pathing (13)
CAR-T (155)
Cell therapy (444)
Cervical cancer (20)
Clinical research (51818)
Collaboration (614)
Compensation (201)
Complete response letters (18)
COVID-19 (1780)
CRISPR (36)
C-suite (140)
Cystic fibrosis (94)
Data (1724)
Decentralized trials (1)
Denatured (15)
Depression (32)
Diabetes (140)
Diagnostics (4427)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (12)
Drug discovery (79)
Drug pricing (30)
Drug shortages (4)
Duchenne muscular dystrophy (62)
Earnings (36847)
Editorial (13)
Employer branding (4)
Employer resources (49)
Events (58694)
Executive appointments (412)
FDA (12215)
Featured Employer (33)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (492)
Gene editing (94)
Generative AI (16)
Gene therapy (275)
GLP-1 (418)
Government (2198)
Grass and pollen (4)
Guidances (26)
Healthcare (11217)
Huntington's disease (20)
IgA nephropathy (23)
Immunology and inflammation (86)
Indications (23)
Infectious disease (1873)
Inflammatory bowel disease (98)
Inflation Reduction Act (2)
Influenza (39)
Intellectual property (62)
Interviews (110)
IPO (8288)
IRA (9)
Job creations (1496)
Job search strategy (461)
Kidney cancer (10)
Labor market (10)
Layoffs (259)
Leadership (13)
Legal (2156)
Liver cancer (66)
Lung cancer (310)
Lymphoma (135)
Machine learning (4)
Management (18)
Manufacturing (188)
MASH (46)
Medical device (8644)
Medtech (8648)
Mergers & acquisitions (8598)
Metabolic disorders (387)
Multiple sclerosis (63)
NASH (11)
Neurodegenerative disease (61)
Neuropsychiatric disorders (14)
Neuroscience (1433)
NextGen: Class of 2025 (3528)
Non-profit (2238)
Northern California (1838)
Now hiring (17)
Obesity (197)
Opinion (129)
Ovarian cancer (71)
Pain (59)
Pancreatic cancer (67)
Parkinson's disease (101)
Partnered (14)
Patents (135)
Patient recruitment (88)
Peanut (41)
People (28046)
Pharmaceutical (26)
Pharmacy benefit managers (2)
Phase I (17269)
Phase II (23422)
Phase III (16530)
Pipeline (879)
Podcasts (44)
Policy (36)
Postmarket research (1345)
Preclinical (7182)
Press Release (65)
Prostate cancer (77)
Psychedelics (22)
Radiopharmaceuticals (160)
Rare diseases (327)
Real estate (3491)
Recruiting (19)
Regulatory (13740)
Reports (22)
Research institute (1878)
Resumes & cover letters (111)
Rett syndrome (3)
RNA editing (3)
RSV (22)
Schizophrenia (42)
Series A (89)
Series B (56)
Service/supplier (4)
Sickle cell disease (57)
Southern California (1458)
Special edition (6)
Spinal muscular atrophy (134)
Sponsored (21)
Startups (2086)
State (1)
Stomach cancer (12)
Supply chain (33)
Tariffs (1)
The Weekly (28)
United States (15184)
Vaccines (425)
Venture capitalists (19)
Webinars (7)
Weight loss (110)
Women's health (25)
Worklife (5)
Date
Last 7 days (461)
Last 30 days (1780)
Last 365 days (23934)
2025 (5947)
2024 (25243)
2023 (28191)
2022 (35062)
2021 (37067)
2020 (34240)
2019 (27372)
2018 (20627)
2017 (20688)
2016 (19164)
2015 (22554)
2014 (15830)
2013 (12800)
2012 (13272)
2011 (13543)
2010 (11584)
Location
Africa (348)
Alabama (39)
Alaska (6)
Arizona (77)
Arkansas (11)
Asia (23740)
Australia (4569)
California (4018)
Canada (1164)
China (375)
Colorado (163)
Connecticut (166)
Delaware (90)
Europe (53027)
Florida (567)
Georgia (143)
Hawaii (1)
Idaho (31)
Illinois (262)
India (13)
Indiana (180)
Iowa (6)
Japan (110)
Kansas (80)
Kentucky (12)
Louisiana (4)
Maine (52)
Maryland (586)
Massachusetts (3173)
Michigan (156)
Minnesota (235)
Mississippi (1)
Missouri (50)
Montana (26)
Nebraska (18)
Nevada (46)
New Hampshire (31)
New Jersey (1120)
New Mexico (24)
New York (1226)
North Carolina (614)
North Dakota (8)
Northern California (1838)
Ohio (143)
Oklahoma (9)
Oregon (28)
Pennsylvania (886)
Puerto Rico (8)
Rhode Island (16)
South America (505)
South Carolina (6)
South Dakota (1)
Southern California (1458)
Tennessee (46)
Texas (619)
Utah (116)
Virginia (93)
Washington D.C. (20)
Washington State (456)
West Virginia (1)
Wisconsin (29)
394,357 Results for "cell design labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellares’ Cell Shuttle™ Receives FDA Advanced Manufacturing Technology (AMT) Designation for Automated Cell Therapy Manufacturing
April 1, 2025
·
3 min read
Press Releases
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)
January 23, 2025
·
5 min read
Press Releases
Secretome Therapeutics Granted FDA Fast Track Designation for STM-01, a Neonatal Cardiac Progenitor Cell Therapy for HFpEF
March 20, 2025
·
2 min read
Press Releases
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
The Company will present at the Annual J.P. Morgan Healthcare Conference, providing business updates on its sarcoma franchise and other cell therapy pipeline assets Adaptimmune Allo-T program to be featured at the Biotech ShowCase(TM) and the Wuxi Global Forum 2025
January 13, 2025
·
5 min read
Press Releases
Avobis Bio Receives FDA Fast Track Designation for AVB-114 Implantable Cell Therapy for Crohn’s Perianal Fistulas
February 28, 2025
·
3 min read
Press Releases
MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
February 26, 2025
·
6 min read
Press Releases
Yingli Pharma Announces Successful End-of-Phase 2 Meeting with FDA and Clearance of Global Multi-center Phase 3 Registration Study Design of Linperlisib for the Treatment of Relapsed and/or Refractory Peripheral T-cell Lymphoma
April 2, 2025
·
3 min read
Press Releases
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
January 28, 2025
·
3 min read
Press Releases
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
February 19, 2025
·
9 min read
Business
Portal Biotechnologies and Multiply Labs Announce Partnership to Automate Cell Engineering In Cell Therapy Manufacturing
Multiply Labs and Portal Biotechnologies announced their collaboration today, combining the efficiency of Multiply Labs’ robotic automation with the differentiated cell engineering capabilities of the Portal platform.
May 21, 2024
·
4 min read
1 of 39,436
Next
